EPISODE · Oct 10, 2019 · 10 MIN
CEO of CytoDyn, Dr. Nader Pourhassan, Shares The Progress of The Company’s Leronlimab Trials with The Stock Day Podcast
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed CytoDyn Inc. (CYDY)(“the Company”), a biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. President and CEO, Dr. Nader Pourhassan, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
Embed this episode
Ready to play
CEO of CytoDyn, Dr. Nader Pourhassan, Shares The Progress of The Company’s Leronlimab Trials with The Stock Day Podcast
No transcript for this episode yet
Similar Episodes
No similar episodes found.